Joan Elizabeth Miller
CIK 1410233 · SVP-Oncology & Neurology Srvcs · last filed 2012-03-02
Joan Elizabeth Miller is a SVP-Oncology & Neurology Srvcs who has filed 33 SEC Form 4 insider transactions across 1 company since 2008. The most recent filing, for DGX, was dated Mar 2, 2012. Across all open-market trades the lifetime net is −$16.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $20.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$20.57M
1
33
-$16.17M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DGX | SVP-Oncology & Neurology Srvcs | 90,279 | $227.90 | $20.57M | -$16.17M | 33 | 2012-03-02 |
Recent Filings
33 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-03-02 | DGX | Mixed | +8,762 | -$295.7K | EDGAR |
| 2012-02-29 | DGX | Grant (A) | +7,097 | $0 | EDGAR |
| 2012-02-27 | DGX | Mixed | — | -$13.2K | EDGAR |
| 2012-02-16 | DGX | Tax (F) | −1,124 | -$63.8K | EDGAR |
| 2012-02-14 | DGX | Tax (F) | −3,368 | -$192.4K | EDGAR |
| 2012-02-07 | DGX | Mixed | — | -$38.0K | EDGAR |
| 2011-11-01 | DGX | Mixed | — | -$101.4K | EDGAR |
| 2011-06-20 | DGX | Sell (S) | −3,815 | -$229.7K | EDGAR |
| 2011-06-16 | DGX | Sell (S) | −4,668 | -$278.7K | EDGAR |
| 2011-06-14 | DGX | Sell (S) | −10,615 | -$628.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.